Literature DB >> 7524772

Quantitative analysis of mutant p53 protein in breast tumor cytosols and study of its association with other biochemical prognostic indicators in breast cancer.

M A Levesque1, E P Diamandis, H Yu, D J Sutherland.   

Abstract

Breast tumors are thought to originate, grow, and metastasize in an environment which includes steroid hormone receptors, their cognate steroid ligands, and many gene products which are regulated by steroid hormone receptor-ligand complexes. In this paper we describe highly sensitive and quantitative immunofluorometric procedures for measuring three proteins that are candidate prognostic indicators in breast cancer, namely, the p53 tumor suppressor gene product, carcinoembryonic antigen (CEA), and prostate specific antigen (PSA). These proteins were quantified in over 950 cytosolic tumor extracts along with estrogen and progesterone receptors (ER, PR). Association analysis between all five biochemical parameters revealed strong negative associations between p53 and receptors and strong positive associations between CEA and receptors. Negative associations between p53 and CEA and between CEA and PSA were also found. These associations, not quantitatively studied in previous reports, are related to each other using a hypothetical model. The observed associations may further contribute to the understanding of the biology of breast tumors.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7524772     DOI: 10.1007/bf00666062

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  62 in total

1.  Genetic mechanisms of tumor suppression by the human p53 gene.

Authors:  P L Chen; Y M Chen; R Bookstein; W H Lee
Journal:  Science       Date:  1990-12-14       Impact factor: 47.728

Review 2.  Breast cancer (1)

Authors:  J R Harris; M E Lippman; U Veronesi; W Willett
Journal:  N Engl J Med       Date:  1992-07-30       Impact factor: 91.245

3.  Meth A fibrosarcoma cells express two transforming mutant p53 species.

Authors:  D Eliyahu; N Goldfinger; O Pinhasi-Kimhi; G Shaulsky; Y Skurnik; N Arai; V Rotter; M Oren
Journal:  Oncogene       Date:  1988-09       Impact factor: 9.867

4.  Is DNA ploidy an independent prognostic indicator in infiltrative node-negative breast adenocarcinoma?

Authors:  S Keyhani-Rofagha; R V O'Toole; W B Farrar; B Sickle-Santanello; J DeCenzo; D Young
Journal:  Cancer       Date:  1990-04-01       Impact factor: 6.860

5.  Patterns of expression of the p53 tumour suppressor in human breast tissues and tumours in situ and in vitro.

Authors:  J Bártek; J Bártková; B Vojtĕsek; Z Stasková; A Rejthar; J Kovarík; D P Lane
Journal:  Int J Cancer       Date:  1990-11-15       Impact factor: 7.396

6.  Node-negative minimal invasive breast cancer patients are not candidates for routine systemic adjuvant therapy.

Authors:  D Rosner; W W Lane
Journal:  Cancer       Date:  1990-07-15       Impact factor: 6.860

7.  Wild-type p53 is a cell cycle checkpoint determinant following irradiation.

Authors:  S J Kuerbitz; B S Plunkett; W V Walsh; M B Kastan
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-15       Impact factor: 11.205

8.  Carcinoembryonic antigen and steroid receptors in the cytosol of carcinoma of the breast. Relationship to pathologic and clinical features.

Authors:  M R Schwartz; R L Randolph; W B Panko
Journal:  Cancer       Date:  1985-05-15       Impact factor: 6.860

9.  Accumulation of p53 tumor suppressor gene protein: an independent marker of prognosis in breast cancers.

Authors:  A D Thor; I I Moore DH; S M Edgerton; E S Kawasaki; E Reihsaus; H T Lynch; J N Marcus; L Schwartz; L C Chen; B H Mayall
Journal:  J Natl Cancer Inst       Date:  1992-06-03       Impact factor: 13.506

10.  Increased p53 protein content of colorectal tumours correlates with poor survival.

Authors:  Y Remvikos; O Tominaga; P Hammel; P Laurent-Puig; R J Salmon; B Dutrillaux; G Thomas
Journal:  Br J Cancer       Date:  1992-10       Impact factor: 7.640

View more
  5 in total

1.  Resveratrol, through NF-Y/p53/Sin3/HDAC1 complex phosphorylation, inhibits estrogen receptor alpha gene expression via p38MAPK/CK2 signaling in human breast cancer cells.

Authors:  Francesca De Amicis; Francesca Giordano; Adele Vivacqua; Michele Pellegrino; Maria Luisa Panno; Donatella Tramontano; Suzanne A W Fuqua; Sebastiano Andò
Journal:  FASEB J       Date:  2011-07-07       Impact factor: 5.191

2.  A novel quantitative immunoassay system for p53 using antibodies selected for optimum designation of p53 status.

Authors:  M D Thomas; G G McIntosh; J J Anderson; D M McKenna; A H Parr; R Johnstone; T W Lennard; C H Horne; B Angus
Journal:  J Clin Pathol       Date:  1997-02       Impact factor: 3.411

3.  Quantification of prostate-specific antigen immunoreactivity in human breast cyst fluids.

Authors:  F Mannello; G Bocchiotti; G Bianchi; F Marcheggiani; G Gazzanelli
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

4.  Tissue carcinoembryonic antigen and oestrogen receptor status in breast carcinoma: an immunohistochemical study of clinical outcome in a series of 252 patients with long-term follow-up.

Authors:  F A Mauri; O Caffo; S Veronese; P Verderio; P Boracchi; M Bonzanini; N Rossi; G Perrone; P Dalla Palma; M Barbareschi
Journal:  Br J Cancer       Date:  1998-05       Impact factor: 7.640

5.  Immunofluorometric analysis of p53 protein and prostate-specific antigen in breast tumours and their association with other prognostic indicators.

Authors:  M A Levesque; G M Clark; H Yu; E P Diamandis
Journal:  Br J Cancer       Date:  1995-09       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.